Advanced Oncotherapy
Financial ratios & Valuation

Historical Multiples (2013 – 2022)

2013 2014 2015 2016 2017 2018 2019 2020 2021 2022 TTM Median
Valuation Ratios
Price/Earnings ratio
-3.29-4.54-15.85-4.43-3.36-2.81-4.06-3.42-4.12N/AN/A-3.36
Price/Sales ratio
187.94319.003.87K5.07KN/AN/AN/AN/AN/AN/AN/AN/A
Price/Book Value ratio
2.413.043.801.351.601.741.972.352.36N/A0.001.74
Price/Cash Flow ratio
-4.40-5.17-10.55-4.19-4.79-35.71-3.59-5.13-4.91N/A-0.00-4.79
Price/Free Cash Flow ratio
-3.52-4.31-7.35-2.22-2.53-4.32-2.37-3.75-3.73N/A-0.00-2.53
Price/Earnings Growth ratio
0.090.370.38-0.14-0.570.120.13-1.980.52N/AN/A-0.57
Dividend Yield
N/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
Profitability Indicator Ratios
Gross Profit Margin
-126.29%-90.52%-25.92%-3718.36%N/AN/AN/AN/AN/AN/AN/AN/A
Operating Profit Margin
-4604.65%-6066.04%-31729.29%-144691.06%N/AN/AN/AN/AN/AN/AN/AN/A
Pretax Profit Margin
-4978.73%-5951.26%-32193.19%-145766.72%N/AN/AN/AN/AN/AN/AN/AN/A
Net Profit Margin
-5711.72%-7015.84%-24456.22%-114390.93%N/AN/AN/AN/AN/AN/AN/AN/A
Effective Tax Rate
-45.30%-38.45%32.26%21.37%17.14%3.47%4.94%-19.89%-19.51%N/AN/A3.47%
Return on Assets
-36.61%-51.59%-21.32%-27.46%-30.08%-35.50%-18.76%-24.80%-24.94%N/AN/A-30.08%
Return On Equity
-73.36%-67.04%-24.03%-30.43%-47.66%-62.08%-48.43%-68.71%-57.43%N/AN/A-47.66%
Return on Capital Employed
-59.14%-57.96%-31.17%-38.50%-50.56%-43.17%-19.79%-19.66%-18.96%N/AN/A-50.56%
Liquidity Ratios
Current Ratio
0.250.954.823.410.741.523.421.37N/AN/A1.260.74
Quick Ratio
0.020.613.541.380.290.401.100.210.30N/A0.090.40
Cash ratio
0.020.432.580.390.000.110.490.120.26N/A0.090.00
Days of Sales Outstanding
N/A0.25N/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
Days of Inventory outstanding
87.062.00K47.77K7.86K7.61K1.91K2.71K3.46K4.02KN/AN/A1.91K
Operating Cycle
87.062.00K47.77K7.86KN/AN/AN/AN/AN/AN/AN/AN/A
Days of Payables Outstanding
5.13K4.22K26.58K3.31K7.48K1.13K879.601.00K834.33N/AN/A1.13K
Cash Conversion Cycle
-5.05K-2.22K21.18K4.54KN/AN/AN/AN/AN/AN/AN/AN/A
Debt Ratios
Debt Ratio
0.290.060.030.010.200.050.410.410.37N/A0.600.20
Debt Equity Ratio
0.590.080.030.010.320.081.081.140.86N/A1.530.32
Long-term Debt to Capitalization
N/AN/AN/AN/AN/AN/A0.510.470.40N/A0.42N/A
Total Debt to Capitalization
0.370.080.030.010.240.080.510.530.46N/A0.490.24
Interest Coverage Ratio
-8.23-14.97-50.39-123.07-11.37-271.86-16.74-4.02N/AN/AN/A-11.37
Cash Flow to Debt Ratio
-0.92-6.63-9.84-20.11-1.03-0.55-0.50-0.39-0.55N/A-0.30-1.03
Company Equity Multiplier
2.001.291.121.101.581.742.582.772.30N/A2.531.58
Cash Flow Ratios
Operating Cash Flow / Sales Ratio
-42.63-61.65-367.27-1.20KN/AN/AN/AN/AN/AN/AN/AN/A
Free Cash Flow / Operating Cash Flow Ratio
1.241.191.431.881.898.261.501.361.31N/A1.668.26
Cash Flow Coverage Ratio
-0.92-6.63-9.84-20.11-1.03-0.55-0.50-0.39-0.55N/A-0.30-1.03
Short Term Coverage Ratio
-0.92-6.63-9.84-20.11-1.03-0.55-14.77-1.76-2.74N/A-1.25-0.55
Dividend Payout Ratio
N/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A